|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Matinas BioPharma Hldgs (AMEX: MTNB) through any online brokerage.
There are no as such competitors for Matinas BioPharma Hldgs.
The latest price target for Matinas BioPharma Hldgs (AMEX: MTNB) was reported by Aegis Capital on August 13, 2020. The analyst firm set a price target for 3.50 expecting MTNB to rise to within 12 months (a possible 407.17% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Matinas BioPharma Hldgs (AMEX: MTNB) is $0.6901 last updated Fri Jan 28 2022 20:59:44 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Matinas BioPharma Hldgs.
Matinas BioPharma Hldgs’s $Q4 earnings are confirmed for after-market on March 28, 2022.
There is no upcoming split for Matinas BioPharma Hldgs.
Matinas BioPharma Hldgs is in the sector and industry. They are listed on the AMEX.